Tat

General Information


DRACP ID  DRACP04750

Peptide Name   Tat

Sequence  RKKRRQRRR

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin 

Type 

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C53H106N30O11

Absent amino acids  ACDEFGHILMNPSTVWY

Common amino acids  R

Mass  148247

Pl  13.2

Basic residues  8

Acidic residues  0

Hydrophobic residues  0

Net charge  8

Boman Index  -10616

Hydrophobicity  -425.56

Aliphatic Index  0

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23776609

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 18656352

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRAMP ID  DRAMP15843

CancerPPD ID  1548

DRACP is developed by Dr.Zheng's team.